Are you tired of constantly trying to lose weight?
Choose Piperinox and enjoy a beautiful figure!
Activates the reduction and maintenance of body weight.
Immediately improves the metabolism of fat and carbohydrates.
Excellent absorption thanks to DRcaps® capsules.
Favorably impacts the absorption of nutrients.
Uses the patented form of piperine - BioPerine®.
One capsule a day is enough to enjoy the maximum effects.
What is piperonox ?
Piperinox are the most effective capsules using the power of piperine. They contain the patented form of BioPerine®, which has a beneficial effect on weight loss, activating metabolism and improving the absorption of nutrients.
What is the difference between BioPerine® and regular piperine
BioPerine® is an innovative form of piperine devoid of chemicals used for growing plants such as: fertilizers, concentrates, nutrients, pesticides or other plant protection products. The safety of its use has been confirmed by the European Food Safety Authority (EFSA). Thanks to better absorption, in comparison to the conventional form, and the use of this form, a significant increase in bioavailability of other valuable components of this supplement is observed. This even leads to a 30-fold increase in its effects. In addition, BioPerine® contains more piperine than black pepper extract, which further intensifies the effectiveness of the product.
Piperine Efficiency guaranteed by DRcaps®
The adequate absorption of active ingredients may be difficult to obtain in the acidic environment of the stomach. This is due to the unfavorable conditions prevailing in it, the low pH of gastric acid can cause the degradation of components, destroy their structure, thus weakening the effect of the supplement. Piperinox, thanks to the use of vegetarian DRcaps® capsules, gets into the intestines, where the valuable ingredients are released, almost intact. All this makes Piperinox a definite number 1 among piperine diet supplements.
Effectiveness of ingredients protection confirmed by testing
The study was designed to observe the in vivo behavior of empty DRcaps® capsules using qualitative and quantitative imaging methods to assess the gastrointestinal transit and release of the DRcaps® capsule content based on the scintigraphic images obtained.
Each examined patient consumed a light meal about 30 minutes before ingesting a DRcaps® capsule containing 300 mg lactose, of which 10 mg was radioactively marked. The photographs in the AP and PA projections were made after taking the capsule, and then every 5 minutes for four hours after administration.
Comments
Post a Comment